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Levels and Patterns of Physical Activity in Children 
and Adolescents With Type 1 Diabetes and Associated 
Metabolic and Physiologic Health Outcomes
Sarah Edmunds, Denise Roche, and Gareth Stratton
Background: The current study objectively 
assessed physical activity (PA) levels and pat-
terns in children and adolescents with type 
1 diabetes and compared the metabolic and 
physiologic health profiles of those achieving 
and those not achieving the current recom-
mendation of 60 minutes a day (minutes·D–1) 
of at least moderate intensity PA. Method: 37 
children and adolescents (20 boys, 17 girls) aged 
12.7 ± 2.1 years (mean ± SD), disease duration 
5.9 ± 3.0 years participated. PA was assessed 
using heart rate monitoring. Peak VO
2
, BMI, 
sum of 5 skinfolds, HbA
1c
, and daily insulin 
dosage were also determined. Results: Mean 
accumulated time in moderate-to-vigorous 
intensity PA was 53.6 ± 31.4 minutes·D–1. 
Levels of vigorous-intensity PA were low, mean 
8.3 ± 10.2 minutes·D–1. When controlling for 
age, no differences in metabolic or physiologic 
health outcomes were evident between those 
individuals achieving, and those not achieving, 
60 minutes·D–1 of moderate-to-vigorous inten-
sity PA. PA predominantly occurred in short 
bouts lasting 5 minutes or less. Conclusion: 
The efficacy of accumulating 60 minutes·D–1 
of moderate-to-vigorous intensity PA, in the 
form of short duration, intermittent bouts of 
largely unplanned PA, to promote health gains 
in children and adolescents with type 1 diabetes 
is questionable.
Keywords: physical activity, exercise, pediatric, 
physical fitness, metabolic health
Physical activity (PA) is recommended to children 
and adolescents with type 1 diabetes as a means of ame-
liorating the known risk factors for vascular disease. In 
particular, PA can be used to improve glycemic control, 
cardiovascular fitness, the lipoprotein profile, and to 
reduce blood pressure.1 Current recommendations are 
that children and young people should achieve a total 
of at least 60 minutes of at least moderate intensity PA 
(MPA) each day.2 It is unclear, however, whether children 
with type 1 diabetes heed the advice and participate in the 
recommended levels of PA to gain health benefits. The 
inherent difficulties associated with objective assessment 
of PA coupled with methodological inconsistencies have 
meant that this is an area that has received little research 
attention and as such, variable findings have so far been 
reported.
PA levels in the patient with type 1 diabetes are 
determined by a complex integration of factors, just as 
they are in children without diabetes, namely biological 
(including age, maturation, gender, motor skill, heredity), 
psychological, pedagogical, and environmental.3 In addi-
tion, health status of the child with type 1 diabetes and 
the burden of the disease and its management may impact 
on PA levels in the patient with type 1 diabetes such as: 
poor knowledge of disease or exercise benefits, parental 
control, poor self efficacy, prior negative experiences.4 
This may mean that children with type 1 diabetes are not 
as active as they should be, even though they are capable 
of sport to the highest level.
Three recent studies have reached contradictory 
conclusions with regard to determining how much PA 
children with type 1 diabetes engage in.5–7 Särnblad 
et al5 found that adolescent girls with type 1 diabetes 
approached the recommended level of 60 minutes of 
at least MPA per day. In direct contrast, Massin et 
al6 reported daily moderate-to-vigorous intensity PA 
(MVPA) levels of just 20 to 25 minutes in boys and girls 
with type 1 diabetes, and Valerio et al7 found 75% of 
their sample did not reach a target of 60 minutes of at 
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least MPA 5 or more times a week. It is therefore unre-
solved as to whether the PA habits of children with type 
1 diabetes are sufficient for immediate and future health 
benefits, or are in fact insufficient to the extent that they 
may contribute to adverse health outcomes.
The differences highlighted above in previous 
research findings may be a result of the methods used to 
assess PA. Objective methods such as continuous heart 
rate monitoring and triaxial accelerometry provide more 
valid data than self-reports of PA.8 This is particularly 
so in children, as they are less conscious of time than 
adults and engage in PA which is chaotic both in time 
and intensity.9 Only Särnblad et al5 and Massin et al6 have 
reported objective data, using uniaxial accelerometry 
and heart rate monitoring respectively. However, the 
reliability of PA data are affected by the number of days 
assessed and Massin et al recorded only 1 day of heart rate 
data per child thus compromising the reliability of their 
data. The strongest study in this area methodologically 
is Särnblad’s who recorded 7 days of accelerometer data 
per child. This resulted, though, in a small sample size 
of 26 which was limited to adolescent girls and gave no 
qualitative information regarding patterns of PA.
The accurate assessment of PA, particularly in chil-
dren, continues to challenge researchers. Accelerometry 
is currently the most commonly used objective method 
of PA assessment in youth10. In epidemiological stud-
ies it is feasible and provides accurate physical activity 
data.11 However, data from accelerometry are typically 
expressed as ‘movement counts,’ and the interpretation of 
these in relation to PA intensity is contentious and varies 
widely between studies.10 Accelerometry is also poor at 
capturing activities such as cycling or hill walking. The 
use of heart rate for the determination of MVPA has not 
received as much attention as accelerometry. Early studies 
were criticized for using universal heart rate intensity cut 
points to assess PA despite large interindividual variation 
in heart rate in young people. This limitation is over-
come, though, if heart rate reserve (HRR), the difference 
between maximum heart rate and minimum heart rate, 
is used to estimate time spent in MVPA, as it allows for 
individual calibration in the interpretation of the data. 
Corder et al10 showed that estimated MVPA from heart 
rate data interpreted using 50% HRR was comparable to 
estimated MVPA from uniaxial accelerometry in the same 
individuals, and concluded that heart rate monitoring has 
the potential to be valuable for the assessment of MVPA. 
In the current study we used heart rate monitoring over 4 
days, interpreted using HRR, to assess PA volumes and 
patterns objectively in girls and boys.
PA assumes an additional role in children with type 
1 diabetes than the general youth population as it is part 
of the diabetes treatment triad (insulin, diet, and PA).1 
A bout of PA can acutely lower blood glucose levels 
and therefore hypothetically repeated bouts over time 
may impact on chronic glycemic control. There have, 
though, been conflicting reports regarding the relationship 
between habitual PA and glycemic control with some 
studies reporting a negative relationship6,7 and others 
reporting no association.5,12 In addition to the metabolic 
benefits, performing adequate PA in type 1 diabetes is 
paramount as it has the potential to ameliorate known 
cardiovascular disease risk factors, such as adiposity, to 
which this population have an increased susceptibility.
The aims of this investigation were therefore 2-fold: 
first, to clarify levels and patterns of PA in children 
and adolescents with type 1 diabetes; and second, to 
determine whether those children achieving the current 
target of 60 minutes·D–1 of at least MPA possess better 
metabolic and physiological health profiles than those 
not achieving the target.
Methods
Participants
Thirty-seven children and adolescents (20 boys and 17 
girls; [mean ± SD] age 12.7 ± 2.1 years), with a dura-
tion of type 1 diabetes of at least 2 years, were recruited 
from 2 National Health Service (NHS) hospitals in the 
North West of England. Participants were excluded if 
they had: secondary disease complications according to 
normal clinical criteria; a chronic illness other than type 1 
diabetes; or were taking medication other than insulin. All 
children were treated with multiple subcutaneous insulin 
injections (2–4 per day). Participant characteristics are 
provided in Table 1. Informed written assent/consent to 
participate in the study was obtained from all children 
and their parent/guardians. Ethical approval for the study 
was obtained from the University Ethics Committee and 
the 2 relevant NHS Trusts.
Anthropometric Measurements
Adiposity was estimated from skinfold thicknesses using 
Harpenden Skinfold Calipers (British Indicators Ltd. 
Birmingham, England). The 5 skinfold sites used were 
the biceps, triceps, subscapular, suprailiac, and medial 
calf. All measurements were taken on the right side of 
the body in triplicate after carefully anatomically locat-
ing and marking. With the skinfold caliper jaws placed 
perpendicular to the raised fold, each skinfold measure-
ment was taken 2 seconds after jaw pressure release. A 
minimum of 3 measurements were taken at each of the 5 
sites and the median value at each site was calculated. The 
sum of 5 skinfolds was determined for each subject as an 
indicator of total body fatness and therefore the problems 
associated with the conversion of skinfold measure-
ments to percentage body fat using skinfold prediction 
equations were avoided.13 Body height was measured 
to the nearest 0.1cm using a wall-mounted stadiometer 
(British Indicators Ltd. Birmingham, England) and body 
weight to the nearest 0.10kg using beam balance scales 
(Avery, Birmingham, England), with subjects wearing 
light clothing, shoes removed. Body mass index (BMI) 
was calculated as body weight divided by body height 
squared (kg/m2).
70  Edmunds, Roche, and Stratton
Determination of Peak VO2 
Participants were fully habituated to the laboratory 
environment and familiarized on relevant equipment 
including the treadmill before commencement of any 
tests. Peak VO
2
 was assessed using a discontinuous, pro-
gressive treadmill exercise test to voluntary exhaustion. 
Following a resting 30μl capillary blood lactate sample 
(Lactate Pro, Arkwray Inc, Shiga, Japan) a 3-minute 
warm-up was performed at 7.6 ± 1.2 km/hr (mean ± SD) 
followed by a further capillary blood lactate sample and 
a short rest. Subjects then began the peak VO
2
 test which 
consisted of 3 minute stages of constant velocity running 
beginning at zero gradient and increasing by 2.5% at the 
end of each 3 minute work-stage. Treadmill test velocity 
was between 7 and 12km·hr–1 (9.0 ± 1.5km·hr–1) and this 
was determined according to age, maturation, and com-
petence during warm-up/familiarization. A rest period of 
60s separated each 3-minute work-stage, during which 
time a blood lactate sample was collected. Expired air 
was collected in meteorological (MET) balloons (Cranlea 
Medical Electronic, Birmingham, England) during the 
final 30s of each work-stage, and the final 30s of the test, 
for determination of expired oxygen and carbon dioxide 
concentrations and total volumes, using precalibrated 
dry-gas analyzers (Servomex 470A and 1400, Servomex, 
Crowborough, England; Harvard Dry Gas Meter, Harvard 
Apparatus, Edenbridge, England respectively). Oxygen 
uptake for each MET balloon was calculated on a PC 
using the Haldane transformation calculations.14 Heart 
rate was measured at 5s intervals throughout the test 
protocol using short range radio telemetry (Polar Sports 
Tester, Kempele, Finland). The highest VO
2
 value attained 
during the test was accepted as peak VO
2
 if test end-point 
criteria had been met, namely subjective fatigue and 
volitional exhaustion, a final heart rate within 10beats.
min–1 of the age-predicted maximum (220-age), and a 
final respiratory exchange ratio of 1.15 or above.15 If 
test-end point criteria were not met, subjects’ peak VO
2
 
data were excluded from the analysis.
Estimation of Habitual PA
Habitual PA was estimated using continuous heart rate 
monitoring (Polar Sportstester, Kempele, Finland), a 
technique which has previously been validated in 5 to 
10 year olds16 and widely used in pediatric research.17,18 
This technique does not permit the direct quantification 
of PA but rather heart rate is instead used to objectively 
determine the relative stress placed on the cardiovascular 
system.
A researcher visited the child’s home at approxi-
mately 8:00 AM and attached and set up a heart rate 
monitor (Polar Sports Tester, Kempele, Finland). This 
consisted of a lightweight transmitter which was attached 
to the child’s chest using either an elasticated belt or 
50mm diameter Skintact foam ECG electrodes and a 
receiver worn on the wrist, which was set to record at 
60s intervals. Children and parents were instructed not 
to modify their usual daily activities and encouraged to 
engage in their normal school, sport, and lifestyle activi-
ties. A researcher returned at approximately 7:00 PM to 
stop and remove the monitor. Heart rate was monitored 
this way on 2 weekdays, and 2 days plus 1 night at the 
weekend. A minimum monitoring period of 3 days is 
recommended for pediatric PA assessment.19 For the 
weekend recording, the monitor was left continuously 
collecting data from 8:00 AM on the Saturday until 
7:00 PM on the Sunday. Subjects also completed a PA 
recall questionnaire,20 at the end of the week in which 
heart rate monitoring was conducted, for heart rate file 
editing purposes.
Heart rate files were downloaded onto a PC for analy-
sis (Polar Precision Performance Software 3.0., Polar, 
Kempele, Finland) and were edited in conjunction with 
the PA recall diary for spurious perturbations or loss of 
skin contact. Percentage HRR (%HRR)21 was used for the 
evaluation of levels of PA at 2 intensities in this study, as 
has been reported in the literature elsewhere.22,23 Resting 
heart rate (an average of the lowest 5 consecutive heart 
rates during sleep) was subtracted from maximal heart 
rate (the value at the end of the peak VO
2
 test) (HR
max
—
HR
rest
) to calculate HRR. Two intensity thresholds were 
calculated: ≥50%HRR and ≥75%HRR corresponding to 
MVPA and VPA respectively.22 The threshold 50%HRR 
is considered to be equivalent to 50% of maximal aerobic 
power, an intensity that is classified as moderate intensity, 
and is the intensity threshold identified in current PA 
guidelines above which health benefits can be secured.2 
The higher VPA threshold, 75% HRR, has recently gained 
prominence in the adult literature for its health benefits.24 
The total accumulated time spent in minutes per day 
above each intensity of HRR was used to establish levels 
of MVPA and VPA for each participant. As no significant 
difference was found between weekend and weekday 
PA, total daily PA above each intensity was determined 
by calculating the mean duration (minutes) over the cor-
responding number of heart rate data collection days.
In addition to the determination of accumulated 
minutes per day of MVPA and VPA, participants’ PA 
patterns were also analyzed in terms of the number of 
times over the collection period (4 days) they engaged in 
MPA (50% to 74%HRR) and VPA (≥75%HRR) activity 
bouts lasting for 5, 10, and 20 minute continuous periods. 
This method permits a more qualitative insight into the 
patterns of PA.
Transmitter interference and/or loss of skin contact 
prevented the procurement of full data sets for each par-
ticipant. Heart rate files were included in the PA analysis 
if their duration lasted a minimum of 8 hours and using 
this criterion 49% of children had complete data sets, 30% 
had 3 complete files, and a further 22% had 2 complete 
files. All participants with 2 or more data files of >8hours 
duration were included in the PA analysis.
Glycemic Control
Glycosylated hemoglobin values (HbA
1c
) for all subjects 
were determined to the nearest 0.1% via latex immuno-
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agglutination inhibition techniques (Bayer DCA 2000, 
Bayer Diagnostics, Newbury, Berkshire, UK) during 
routine clinical monitoring. The HbA
1c
 measurements 
were taken within 6 weeks of both the laboratory visit 
and assessment of PA. The normal laboratory values for 
nondiabetic individuals are between 2.0 and 6.5%.
Data Analysis
Statistical analysis was performed using SPSS for 
Windows (Version 16.0). Normality was tested using 
the Kolmogorov-Smirnov test. Independent t tests were 
used to determine whether gender differences existed 
in physiological characteristics, heart rate variables, or 
levels of PA between boys and girls. Two activity groups 
were created based on whether participants achieved 
current PA recommendations,2 namely <60 minutes·D–1 
above 50%HRR (low-active) and ≥60 minutes·D–1 above 
50%HRR (high-active). Differences in physiological and 
metabolic characteristics between the 2 activity groups 
were assessed using Analysis of Covariance (ANCOVA) 
with activity group the fixed factor and age a covariate. 
Assumptions for use of ANCOVA such as equality of vari-
ance and homogeneity of regression slopes were tested 
and met for all dependent variables tested therefore data 
are untransformed. Statistical significance was set at P < 
.05 throughout. Means ± SD are reported.
Results
Independent t tests revealed that sum of 5 skinfolds was 
significantly greater in the girls in the study compared 
with the boys (P < .01), as shown in Table 1. This was also 
true for BMI (P < .01). There were no other significant 
differences between the girls and boys in the study in 
their physiological or clinical characteristics.
Heart rate monitoring and the maximal treadmill 
incremental test revealed that mean resting heart rate 
and mean maximal heart rate were 67.1 ± 8.1 and 204.5 
± 7.6 bpm respectively, which produced mean HRR 
thresholds at 50% and 75% of 136.1 ± 5.7 and 170.5 ± 
6.0bpm respectively (Table 2). No significant differences 
were evident in resting, maximal, 50%HRR or 75%HRR 
thresholds between boys and girls (P > .05).
The mean accumulated time spent performing MVPA 
for all study participants was 53.6 ± 31.4 minutes·D–1. 
As shown in Figure 1, boys tended to perform more PA 
Table 1 Clinical, Physiological and Anthropometric Characteristics
of Participants for Whole Group and by Gender
Parameter Girls Boys All
Age (years) 13.2 ± 1.9 12.6 ± 2.3 12.9 ± 2.1
Disease duration (years) 6.4 ± 3.0 5.5 ± 3.0 5.9 ± 3.0
Weight (kg) 54.5 ± 12.7 44.0 ± 13.2 48.9 ± 13.8
Height (cm) 153.6 ± 11.2 151.9 ± 14.3 150.4 ± 12.8
BMI (kg/m2) 23.2 ± 4.3** 18.9 ± 2.5 21.0 ± 4.0
HbA
1c
 (%) 9.9 ± 1.7 9.6 ± 1.6 9.7 ± 1.6
Daily insulin dosage (U) 59.6 ± 18.8 50.9 ± 21.5 54.9 ± 20.8
SBP (mmHg) 112.3 ± 7.8 110.8 ± 9.0 111.5 ± 8.3
DBP (mmHg) 70.0 ± 12.5 66.9 ± 9.5 68.3 ± 11.1
Peak VO
2
39.6 ± 9.2 43.3 ± 7.3 41.9 ± 8.3
Sum of 5 skinfolds 77.2 ± 38.9** 50.1 ± 14.6 62.0 ± 32.4
Note. Data are expressed as mean ± SD. The groups were compared using independent t tests. * P < .05, 
** P < .01, significant difference between boys and girls.
Table 2 Mean Heart Rate Values (± SD) Including Resting, Maximum 
and Percentage of HRR for Whole Group, and Also by Gender
Variable Girls Boys All
HR
rest
68.1 ± 7.8 66.2 ± 8.5 67.1 ± 8.1
HR
max
204.4 ± 8.2 204.5 ± 7.3 204.5 ± 7.6
50%HRR 136.6 ± 6.1 135.8 ± 5.5 136.1 ± 5.7
75%HRR 170.5 ± 6.6 170.5 ± 5.6 170.5 ± 6.0
Note. Data are expressed as mean ± SD. The groups were compared using independent t tests. * P < .05, 
**P < .01, significant difference between boys and girls.
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at this moderate-to-vigorous intensity compared with the 
girls (62.2 ± 31.5 vs. 43.5 ± 29.1 minutes·D–1), but this 
difference was not significant (P > .05). Overall, 41% of 
the children with type 1 diabetes attained the target of 
60minutes.D–1 of at least MPA. Low levels of VPA were 
displayed by the children with a mean accumulated time 
spent performing VPA of 8.3 ± 10.2 minutes·D–1 for the 
whole group. Higher levels of VPA were performed by 
the boys daily compared with the girls in the study (12.6 
± 12.0 vs. 3.4 ± 3.5 minutes·D–1, P < .05), see Figure 1.
Analysis of variance revealed that those children in 
the high-active group were significantly younger (P < 
.005) than those in the low-active group. When age was 
controlled for, ANCOVA revealed that there were no 
significant differences between the low- and high-active 
groups for HbA
1c
 or daily insulin dosage (U·kg–1) (Table 
3). Likewise, peak VO
2
, BMI, and the sum of 5 skinfolds 
were not significantly different between the low- and high 
active groups when age was controlled for.
PA patterns of participants were also established by 
calculating the frequency of MPA and VPA activity bouts 
lasting for 5, 10, and 20 minute continuous periods over 
the heart rate monitoring period (4 days). The PA patterns 
of participants are shown in Table 4. The most common 
duration of MPA undertaken by the boys and girls was a 
5 minute bout, with the majority of boys and girls achiev-
ing 3 or more 5 minute bouts of continuous activity over 
the 4 collection days (90.0% of boys, 58.8% of girls). A 
number of children performed 3 or more sustained 10 
minute bouts of MPA over the 4 collection days (boys 
50.0%; girls 29.4%) although performance of just 1 or 2 
continuous 10 minute bouts of MPA over the collection 
period was more common in both sexes. Few children 
partook in 20 minute continuous bouts of MPA with 
85.0% of girls and 45.0% of boys failing to undertake 
a single 20 minute bout of MPA in 4 days of heart rate 
monitoring.Sustained periods of VPA lasting more than 
5 minutes were infrequent in both boys and girls. Forty 
percent of boys and 64.7% of girls failed to perform a 
single continuous 5 minute bout of VPA over the 4 days of 
heart rate monitoring. Similarly, 60% of boys and 100% 
of girls failed to record a 10 minute bout of VPA over the 
data collection period and this figure increased to 85% 
and 100% for boys and girls respectively for sustained 
20 minute bouts of VPA.
Figure 1 — Mean daily accumulated physical activity (minutes·D–1) for boys and girls for MVPA (>50%HRR) and VPA (>75%HRR). 
Error bars depict +SD. * Between groups P < .05.
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Table 3 Clinical, Physiological, and Anthropometric Characteristics of participants Based
on PA Status
Variable High-active Low-active ANCOVA
n 15 22 —
Gender 12 boys, 3 girls 8 boys, 14 girls —
Age (years) 11.7 ± 1.9 13.6 ± 1.8 Groupa
Disease duration (years) 5.9 ± 2.8 5.9 ± 3.2 Groupa
Weight (kg) 43.1 ± 10.8 54.7 ± 14.4 Ageb
Height (cm) 150.0 ± 11.3 155.7 ± 13.8 Ageb
BMI 19.1 ± 3.1 22.5 ± 4.2 Nonsignificant
HbA
1c
 (%) 9.5 ± 1.2 10.0 ± 1.9 Nonsignificant
Daily insulin dosage (U) 48.3 ± 19.3 63.0 ± 20.2 Ageb
Daily insulin dosage (U·kg-1) 1.4 ± 0.5 1.2 ± 0.2 Nonsignificant
Peak VO
2
40.5 ± 7.5 42.2 ± 9.5 Nonsignificant
Sum of 5 skinfolds 58.6 ± 30.1 72.1 ± 34.1 Nonsignificant
Note. Data represent mean ± SD. The two physical activity groups were compared using analysis of covariance (ANCOVA) with age the covariate 
unless otherwise specified. 
a P < .005 between groups ANOVA (without age adjustment).
b P < .001 ANCOVA.
Table 4 The Distribution of Bouts of MPA (50–74%HRR) and VPA (≥75%HRR) Lasting 5, 10, and 
20 Consecutive Minutes, in Girls and Boys Over 2 Week Days and 2 Days at the Weekend (4 Days 
Total); Expressed as Number of Participants (% of Participants)
Duration of bout
No. of 
bouts
MPA (50–74%HRR) VPA (≥75%HRR)
Boys (n = 15) Girls (n = 14) Boys (n = 15) Girls (n = 14)
5 minutes
0 1 (5.0) 3 (17.6) 8 (40.0) 11 (64.7)
1 1 (5.0) 2 (11.8) 2 (10.0) 5 (29.4)
2 0 (0) 2 (11.8) 3 (15.0) 1 (5.9)
≥3 18 (90.0) 10 (58.8) 7 (35.0) 0 (0)
10 minutes
0 3 (15.0) 3 (17.6) 12 (60.0) 17 (100)
1 3 (15.0) 5 (29.4) 6 (30.0) 0 (0)
2 4 (20.0) 4 (23.6) 0 (0) 0 (0)
≥3 10 (50.0) 5 (29.4) 2 (10.0) 0 (0)
20 minutes
0 9 (45.0) 15 (88.2) 17 (85.0) 17 (100)
1 5 (25.0) 1 (5.9) 2 (10.0) 0 (0)
2 1 (5.0) 1 (5.9) 1 (5.0) 0 (0)
≥3 5 (25.0) 0 (0) 0 (0) 0 (0)
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Discussion
Regular PA is associated with health and well-being ben-
efits for children, including those with type 1 diabetes.1 To 
help in the promotion of active lifestyles, guidelines have 
been developed about the amount of PA that is required 
to maintain children’s current and future health, these 
are currently at least 60 minutes·D–1 of at least MPA.2 
PA should be promoted with caution to children with 
type 1 diabetes as it can have positive, but also negative, 
consequences depending on their insulinemic and gly-
cemic state before exercise.25,26 However, the American 
Diabetes Association position statement1 on PA and 
exercise states that children who are free from second-
ary complications can participate safely in PA so long as 
they have careful instructions in self management and the 
treatment of hypoglycemia. In the current study we found 
that in a representative group of boys and girls with type 
1 diabetes, and no secondary complications, only 41% 
are achieving the recommended target of 60minutes·D–1. 
Therefore, over half of children in this sample are miss-
ing out on potential health benefits of PA and, in fact, 
may be adversely affecting their future health by leading 
insufficiently active lifestyles.
Comparison between studies in this area is difficult 
due to the use of different measurement instruments and 
protocols to assess PA. In respect of previous research 
involving young people with type 1 diabetes, the PA 
levels of our participants partly concur with the recent 
findings of Massin et al6 and Valerio et al7 who reported 
that children with type 1 diabetes have PA levels below 
the recommended threshold. More detailed analysis 
of our data identified gender differences in the daily 
accumulation of MVPA with girls demonstrating lower 
mean levels (44 minutes·D–1) than boys (62 minutes·D–1). 
Translated as percentages our data reveal that only 60% 
of boys and 23.5% of girls in the current study actually 
accumulated 60 minutes·D–1 of MVPA, leaving large 
proportions of both boys (40%) and girls (76.5%) in the 
category of suboptimal PA. This latter finding contrasts 
fairly sharply with the research of Särnblad et al5 whereby 
it was reported that girls aged 12 to 16 years with diabetes 
achieve the 60 minutes·D–1 recommendation. Unlike the 
current study which used heart rate monitoring and a 
threshold of >50% HRR to identify MVPA, Särnblad’s 
data comes from uniaxial accelerometry whereby a cut-
off of 1952 counts/min was used to define MVPA. There 
was no evidence presented in the Särnblad paper that use 
of the accelerometer count range of >1952 counts/minute 
to correspond to the predefined PA intensity of moderate 
or higher was empirically calibrated from simulated PA 
such as running, walking or free-living activity. Given that 
accelerometer counts used to define MVPA range widely, 
from >300 to >3200 counts per minute,27 it is question-
able whether the raw accelerometer signal characterizes 
a physiological phenomenon such as PA behavior as well 
as it might without a biological translation. Therefore, 
although the variety of methodologies used to assess PA 
levels in the pediatric population makes synthesis of these 
data more complicated, the main body of evidence, com-
bined with our findings, seems to suggest that PA levels 
are below optimal levels in children with type 1 diabetes.
Suboptimal levels of PA, as found in the current 
study, are not unique to children and adolescents with 
type 1 diabetes, and previous research suggests that chil-
dren and adolescents without type 1 diabetes also fail to 
accumulate 60 minutes·D–1 of at least MPA.23,28 A review 
of 26 studies23 concluded that healthy young people aged 
3 to 17 years perform on average 44 minutes·D–1 above 
the 50%HRR threshold, which is inferior to our group 
mean of 54 minutes·D–1 in children with type 1 diabetes 
at the same intensity. In addition to demonstrating that 
the girls with type 1 diabetes in the current study were 
less likely than their male counterparts to be adequately 
active, it was also apparent that the younger participants 
were more likely to achieve the 60 minute MVPA daily 
target than their older peers. These age and gender related 
observations are also synonymous with the wider research 
literature involving nondiabetic children and adolescents 
and so our trends do not appear to be exclusive to patients 
with type 1 diabetes.23,28–30 Our study, like others, has 
identified adolescent females as being the most suscep-
tible group to low levels of PA.
An important finding from our data is that VPA may 
be particularly low in children and adolescents with type 1 
diabetes. VPA has recently been highlighted as important 
for health benefits and the American College of Sports 
Medicine PA recommendations for adults have been 
revised to reflect this.24 The guidelines for children have 
not been revised but data from the Amsterdam growth 
and health study found participation in greater VPA was 
predictive of reduced coronary heart disease risk fac-
tors.31 The present data showed children participated in 
low levels of VPA, accumulating just 8 minutes per day 
on average, and analysis by gender revealed a significant 
difference with worryingly low levels of VPA in girls. In 
adults there is convincing evidence that VPA has a clearer 
association with coronary heart disease risk reduction 
than MPA32 and that higher levels of VPA are inversely 
correlated with coronary heart disease risk. Certainly if 
VPA in childhood predicts adult vascular-related mortal-
ity or morbidity, the type 1 diabetic patients in this study 
disadvantage their health further than the natural etiology 
of the disease already ordains, through such low levels of 
VPA. Future research should elucidate the value of VPA 
as opposed to MPA on short- and long-term metabolic 
and vascular health in type 1 diabetes.
Since PA is known to have an acute blood glucose 
lowering effect26 and to increase insulin sensitivity in type 
1 patients with diabetes,33 the hypothesis that habitual 
PA will be associated with greater metabolic control has 
been investigated by previous authors, but results have so 
far proved inconclusive. We therefore conducted a series 
of comparisons between high and low active individuals 
to determine whether physiologic health indicators and 
metabolic characteristics, which are linked to diabetic 
comorbidity risk, differed by activity status. ANCOVA 
revealed that there were no differences between the high-
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active and low-active groups in either glycemic control 
or daily insulin dosage (U·kg–1) when age was controlled 
for. Likewise, adiposity represented by BMI and the sum 
of 5 skinfolds, although lower in the high-active group, 
did not significantly differ between groups when age was 
controlled for. Lastly, peak VO
2
, an indicator of cardiore-
spiratory fitness and a strong predictor of cardiovascular 
disease risk, did not significantly differ between the 2 
activity groups. Therefore our data suggest that in this 
group of young type 1 patients with diabetes, accumulat-
ing 60 minutes of MVPA daily does not translate into a 
superior physiologic or metabolic health profile.
Insofar as glycemic control is concerned, it is pos-
sible that we did not detect differences between the high- 
and low-active groups because of the effects of puberty on 
HbA
1c
. Hormonal changes that occur during adolescence 
create additional difficulties for controlling HbA
1c
 which 
may counter the salutary effects of PA. Cross-sectional 
and interventional studies have demonstrated that PA 
positively impacts on glycemic control in children up to 
the age of 12 years6,34 but not in teenagers.35 In accord 
with previous research therefore, we speculate, that dif-
ferences in glycemic control according to activity status 
may be more readily apparent in younger children not 
undergoing pubertal hormone fluctuations, but limited 
numbers in this study precluded further analyses by age 
while the confounding effects of insulin dose and regimen 
and calorie intake were controlled for.
Furthermore analysis of PA patterns displayed by 
our participants indicated that repeated short bouts of 
MPA are being undertaken, mainly 5 minutes in duration 
or less, interspersed with periods of low-intensity activ-
ity or rest. Ten and twenty minute continuous bouts of 
activity above the moderate intensity threshold are less 
common and in fact, the latter are extremely rare in the 
girls. Although mean total MVPA for the whole group 
was 54 minutes·D–1, this was accumulated through short 
sporadic bursts of predominantly moderate intensity 
activity and was not continuous or vigorous, a finding 
which is reflected in the wider pediatric literature.17 As 
discussed above adult PA recommendations have been 
amended to explicitly include VPA, a proviso was also 
added that while PA targets may still be reached by accu-
mulating PA over the day, for bouts of activity to count, 
they need to be a minimum of 10 minutes in duration.24 
Therefore, given the children achieving 60 minutes·D–1 in 
the current study were not significantly different in their 
glycemic control or physiological profiles than those not 
achieving 60 minutes·D–1, we question whether repeat-
edly performing short (1–5 minute) episodes of MPA is 
the most fruitful format for type 1 patients with diabetes 
to gain metabolic and physiologic health benefits.
Short, unplanned bouts of PA are a challenge to the 
patient with type 1 diabetes due to the complexity of 
the neuro-hormonal response to exercise in this popula-
tion. For exercise to be positive rather than detrimental 
metabolically, there is a need for a good insulinemic25 
and glycemic state26 before exercise. Research tells us 
that the type (continuous or intermittent), duration, and 
timing of exercise dictate the subsequent blood glucose 
and counter-regulatory hormonal response. More specifi-
cally, exercise which includes intermittent short bouts 
of high intensity work produces a significantly higher 
epinephrine response to a single continuous moderate-
intensity bout in type 1 diabetes.36 The altered counter-
regulatory hormone responses to intermittent versus 
continuous exercise is considered to partly contribute 
to the attenuated BG lowering effect and elevated blood 
lactate response of intermittent exercise.36 Therefore, 
given the established importance of exercise type on the 
metabolic cost of an exercise bout, the intermittent pat-
terns of PA displayed by the children and adolescents in 
the current investigation will by necessity impact upon 
substrate utilization and ultimately the efficacy of exercise 
for improving glycemic control, adiposity, and oxidative 
metabolism (peak VO
2
). We suggest that the therapeutic 
value of well anticipated exercise of a more continuous 
nature as opposed to the short sporadic bouts seen in this 
study are worthy of further investigation with a view to 
optimizing exercise prescription guidelines for type 1 
diabetes.
A limitation from this study was that numbers 
prevented us from analyzing the sample further by age 
and gender. As discussed above, hormonal fluctuations 
during puberty may counter the effects of PA and future 
studies should thus ensure a large enough sample size 
to allow more detailed analyses which separate children 
and adolescents. Although we have identified some novel 
data with regard to PA patterns in children and adoles-
cents with type 1 diabetes the generalizability of our 
findings will be to some extent affected by our sample 
size and the study may in part, require some replication 
on a larger scale. In addition the use of cross-sectional 
data precludes the interpretation of cause and effect in 
the relationships between PA and metabolic and physi-
ologic factors. Future research using longitudinal and 
intervention designs should be conducted to investigate 
the causality of any relationships between PA and meta-
bolic and physiologic factors.
A strength of the current study’s design is its detailed 
analysis of PA patterns and intensity. Analysis of this type 
will help in our understanding of the relative benefits 
of PA of varying duration, frequency, and intensity for 
children with type 1 diabetes. The validity of heart rate 
monitoring as a method for assessing physical activity in 
youth has been confirmed. Heart rate is strongly related 
to oxygen consumption and energy expenditure across a 
wide range of values.37–39
In conclusion, we have determined that PA levels of 
young type 1 patients with diabetes are suboptimal and a 
large proportion are failing to achieve the recommended 
60 minutes·D–1 MPA threshold,2 especially adolescent 
girls. Daily PA tends to be made up of short duration bouts 
of activity rather than continuous or sustained activity, 
mimicking the patterns seen in nondiabetic children and 
adolescents. Accumulating 60 minutes of MVPA daily 
did not translate into superior glycemic control or a better 
physiological health profile in this sample, and this could 
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be due to the way in which PA is being performed. PA 
should still be promoted in children and adolescents with 
type 1 diabetes as it is invaluable in this population for 
its ability to impact on adult health and ameliorate risk 
factors for peripheral and cardiovascular complications 
to which people with type 1 diabetes are predisposed.1 
Future research should determine the optimal exercise 
prescription for young people with type 1 diabetes by 
comparing the medium-term metabolic and physiological 
effects of continuous versus short repeated bouts of PA.
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